Neuraminic acid

Last updated on: 14.11.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Neuraminic acid was discovered and named by Ernst Klenk in 1941. He chose the trivial name in connection with the natural occurrence of neuraminic acid in the brain, where it is not present in free form, but as part of a ganglioside. Isolation from the brain was particularly challenging for this reason and also because of the sensitivity of neuraminic acid to acids, for example.

DefinitionThis section has been translated automatically.

Neuraminic acid is an amino sugar acid of the type of a usonic acid or ketoaldonic acid. It consists of a linear chain nine carbon atoms long (hence "nonulosonic acid"), whereby the configuration of carbon atoms 4 to 7 corresponds to that of galactose. Chemically, however, neuraminic acid can be seen as a formal condensation product of pyruvate with mannosamine. The derivatives of neuraminic acid are collectively referred to as sialic acids, whereby this group term also covers further modified substances, such as derivatives in which the usual hydroxyl group is present instead of the amino group.

LiteratureThis section has been translated automatically.

  1. Klenk E (1956) Chemistry and biochemistry of neuraminic acid. Applied Chemistry 68: 349-352
  2. Huizing M et al (2021) FSASD Consortium. Free sialic acid storage disorder: Progress and promise. Neurosci Lett 755:135896.
  3. Zielonka M et al. (2019) A cross-sectional quantitative analysis of the natural history of free sialic acid storage disease-an ultra-orphan multisystemic lysosomal storage disorder. Genet Med 21:347-352

Last updated on: 14.11.2024